Related Experiment Video
Updated: Apr 17, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Potential use of probiotic and commensal bacteria as non-antibiotic strategies against vancomycin-resistant
Laureen Crouzet1, Lionel Rigottier-Gois1, Pascale Serror2
1INRA, UMR1319 Micalis, F-78350 Jouy-en-Josas, France; and AgroParisTech, UMR Micalis, F-78350 Jouy-en-Josas, France.
Abstract:
Vancomycin-resistant enterococci (VRE) represent major opportunistic pathogens in immunocompromised populations. Particularly adapted to the hospital environment, VRE efficiently colonize the gastrointestinal (GI) tract of patients. Furthermore, certain circumstances of antibiotic-induced dysbiosis of the gut microbiota contribute to colonization, overgrowth and persistence of VRE in the GI tract, increasing the risk of infection in critically ill and/or severally immunocompromised patients. VRE treatment with antibiotics remains challenging due to the robustness and ability of enterococci to adapt to harsh conditions and to acquire novel resistance genes. Reducing VRE intestinal colonization, overgrowth and carriage has thus become an important issue to reduce the risk of infection and dissemination. This review summarizes the knowledge of the conditions favoring VRE colonization and persistence in the GI tract and focuses on the strategies to reduce overgrowth or persistence of VRE in the GI tract based on the oral administration of probiotic or commensal bacteria in human studies and in animal models, and on the potential underlying mechanisms of the anti-VRE effect.
Insights
Vancomycin-resistant enterococci (VRE) are dangerous hospital pathogens that colonize the gut. Probiotic bacteria show promise in reducing VRE gut colonization and infection risk.
Area of Science:
- Microbiology
- Infectious Diseases
- Gastroenterology
Background:
- Vancomycin-resistant enterococci (VRE) are opportunistic pathogens prevalent in hospital settings.
- VRE colonization of the gastrointestinal tract is facilitated by antibiotic-induced gut dysbiosis.
- VRE infections pose a significant threat to immunocompromised patients, complicated by antibiotic resistance.
Purpose of the Study:
- To review factors promoting VRE colonization and persistence in the GI tract.
- To explore strategies for reducing VRE overgrowth and carriage in the gut.
- To assess the efficacy of probiotic and commensal bacteria in combating VRE.
Main Methods:
- Literature review of studies on VRE colonization and persistence.
- Analysis of human and animal studies investigating probiotic/commensal bacteria interventions.
- Examination of potential mechanisms of anti-VRE effects.
Main Results:
- Antibiotic-induced dysbiosis creates favorable conditions for VRE colonization.
- Oral administration of certain probiotic and commensal bacteria demonstrates potential in reducing VRE.
- Mechanisms of action include competitive exclusion and modulation of the gut microbiota.
Conclusions:
- Reducing VRE intestinal colonization is crucial for infection prevention.
- Probiotic and commensal bacteria represent a promising therapeutic strategy against VRE.
- Further research into the mechanisms of anti-VRE effects is warranted.
More Related Videos
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Biological Methods for Microbial Control
Probiotics
Inhibitors of Gram-positive Cell Wall Synthesis

